188 related articles for article (PubMed ID: 12605322)
1. Transient panhypogammaglobulinaemia and B-lymphocyte deficiency in a patient with neuropsychiatric systemic lupus erythematosus after immunosuppressive therapy.
Song J; Park YB; Suh CH; Lee SK
Clin Rheumatol; 2003 Feb; 22(1):62-6. PubMed ID: 12605322
[TBL] [Abstract][Full Text] [Related]
2. Echolalia as a novel manifestation of neuropsychiatric systemic lupus erythematosus.
Zapor M; Murphy FT; Enzenauer R
South Med J; 2001 Jan; 94(1):70-2. PubMed ID: 11213948
[TBL] [Abstract][Full Text] [Related]
3. B cell loss leading to remission in severe systemic lupus erythematosus.
Tarrant TK; Frazer DH; Aya-Ay JP; Patel DD
J Rheumatol; 2003 Feb; 30(2):412-4. PubMed ID: 12563705
[TBL] [Abstract][Full Text] [Related]
4. Fulminant onset of cerebral immunocomplex vasculitis as first manifestation of neuropsychiatric systemic lupus erythematosus (NPSLE).
Rizos T; Siegelin M; Hähnel S; Storch-Hagenlocher B; Hug A
Lupus; 2009 Apr; 18(4):361-3. PubMed ID: 19276305
[TBL] [Abstract][Full Text] [Related]
5. [Neurological disorders in systemic lupus erythematosus patients].
Hawro T; Bogucki A; Sysa-Jedrzejowska A; Bogaczewicz J; Woźniacka A
Pol Merkur Lekarski; 2009 Jan; 26(151):43-8. PubMed ID: 19391506
[TBL] [Abstract][Full Text] [Related]
6. Persistent immunoglobulin deficiency after prednisolone and antiepileptic therapy in a C2 deficient patient with lupus-like syndrome.
Woo P; Pereira RS; Lever AM
J Rheumatol; 1984 Dec; 11(6):828-31. PubMed ID: 6520837
[TBL] [Abstract][Full Text] [Related]
7. Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients.
Yu HH; Wang LC; Lee JH; Lee CC; Yang YH; Chiang BL
Rheumatology (Oxford); 2007 Sep; 46(9):1492-4. PubMed ID: 17673480
[TBL] [Abstract][Full Text] [Related]
8. [Initial manifestation by cerebral vasculitis in systemic lupus erythematosus].
Mrabet D; Meddeb N; Sahli H; Rammeh N; Sellami S
Tunis Med; 2008 Jun; 86(6):618-9. PubMed ID: 19216467
[No Abstract] [Full Text] [Related]
9. Management of hypogammaglobulinaemia occurring in patients with systemic lupus erythematosus.
Yong PF; Aslam L; Karim MY; Khamashta MA
Rheumatology (Oxford); 2008 Sep; 47(9):1400-5. PubMed ID: 18625660
[TBL] [Abstract][Full Text] [Related]
10. Correlation of magnetization transfer ratio histogram parameters with neuropsychiatric systemic lupus erythematosus criteria and proton magnetic resonance spectroscopy: association of magnetization transfer ratio peak height with neuronal and cognitive dysfunction.
Emmer BJ; Steup-Beekman GM; Steens SC; Huizinga TW; van Buchem MA; van der Grond J
Arthritis Rheum; 2008 May; 58(5):1451-7. PubMed ID: 18438847
[TBL] [Abstract][Full Text] [Related]
11. Cerebellar ataxia in systemic lupus erythematosus.
Appenzeller S; Cendes F; Costallat LT
Lupus; 2008 Dec; 17(12):1122-6. PubMed ID: 19029281
[TBL] [Abstract][Full Text] [Related]
12. [Systemic lupus erythematosus].
Hirohata S
Nihon Rinsho; 2004 Jan; 62 Suppl():429-34. PubMed ID: 15011400
[No Abstract] [Full Text] [Related]
13. Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature.
García-Moreno JM; Chacón J
Mov Disord; 2002 Nov; 17(6):1329-35. PubMed ID: 12465077
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of cerebral large vessel vasculitis in systemic lupus erythematosus with intravenous pulse cyclophosphamide.
Kato R; Sumitomo S; Kawahata K; Fujio K; Yamamoto K
Lupus; 2015 Jul; 24(8):880-4. PubMed ID: 25661835
[TBL] [Abstract][Full Text] [Related]
15. Diffusion changes in patients with systemic lupus erythematosus.
Zhang L; Harrison M; Heier LA; Zimmerman RD; Ravdin L; Lockshin M; Uluğ AM
Magn Reson Imaging; 2007 Apr; 25(3):399-405. PubMed ID: 17371731
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of vasculitis of the central nervous system in a patient with systemic lupus erythematosus.
Nikolov NP; Smith JA; Patronas NJ; Illei GG
Nat Clin Pract Rheumatol; 2006 Nov; 2(11):627-33; quiz 634. PubMed ID: 17075602
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychiatric lupus and reversible posterior leucoencephalopathy syndrome: a challenging clinical dilemma.
Mak A; Chan BP; Yeh IB; Ho RC; Boey ML; Feng PH; Koh DR; Ong BK
Rheumatology (Oxford); 2008 Mar; 47(3):256-62. PubMed ID: 18084001
[TBL] [Abstract][Full Text] [Related]
19. Neurogenic bladder in a patient with systemic lupus erythematosus and cerebral involvement.
Kim HA; Ye YM; Choi JB; Park HS; Suh CH
J Clin Rheumatol; 2009 Feb; 15(1):40-1. PubMed ID: 19125134
[No Abstract] [Full Text] [Related]
20. Cerebral and corpus callosum atrophy in systemic lupus erythematosus.
Appenzeller S; Rondina JM; Li LM; Costallat LT; Cendes F
Arthritis Rheum; 2005 Sep; 52(9):2783-9. PubMed ID: 16142703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
